SEC23B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.657600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.705760E-01
Normal-vs-Stage2
8.380600E-01
Normal-vs-Stage3
8.423700E-02
Normal-vs-Stage4
9.644000E-01
Stage1-vs-Stage2
2.558400E-01
Stage1-vs-Stage3
4.763800E-03
Stage1-vs-Stage4
1.862560E-01
Stage2-vs-Stage3
6.136200E-02
Stage2-vs-Stage4
7.785600E-01
Stage3-vs-Stage4
1.361980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.665600E-01
Normal-vs-AfricanAmerican
2.664000E-01
Normal-vs-Asian
8.002600E-01
Caucasian-vs-AfricanAmerican
2.664600E-01
Caucasian-vs-Asian
3.409400E-01
AfricanAmerican-vs-Asian
8.265900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.404200E-01
Normal-vs-Female
8.014400E-01
Male-vs-Female
6.907400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.064800E-01
Normal-vs-Age(41-60Yrs)
5.588800E-01
Normal-vs-Age(61-80Yrs)
8.592800E-01
Normal-vs-Age(81-100Yrs)
8.713000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.528400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.099200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.523000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.699640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.871600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.602600E-01
Normal-vs-Daily Drinker
5.148000E-01
Normal-vs-Weekly Drinker
7.957000E-01
Normal-vs-Occasional Drinker
3.973400E-01
Normal-vs-Social Drinker
6.664800E-01
Non Drinker-vs-Daily Drinker
2.951000E-01
Non Drinker-vs-Weekly Drinker
6.802000E-01
Non Drinker-vs-Occasional Drinker
5.063800E-02
Non Drinker-vs-Social Drinker
3.341600E-01
Daily Drinker-vs-Weekly Drinker
6.625200E-01
Daily Drinker-vs-Occasional Drinker
1.382140E-02
Daily Drinker-vs-Social Drinker
1.258190E-01
Weekly Drinker-vs-Occasional Drinker
4.098400E-02
Weekly Drinker-vs-Social Drinker
2.589800E-01
Occasional Drinker-vs-Social Drinker
4.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.096800E-01
Normal-vs-Grade 2
8.398800E-01
Normal-vs-Grade 3
7.725200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.250100E-02
Grade 1-vs-Grade 3
1.437360E-01
Grade 1-vs-Grade 4
4.096800E-01
Grade 2-vs-Grade 3
2.239200E-01
Grade 2-vs-Grade 4
8.398800E-01
Grade 3-vs-Grade 4
7.725200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.992800E-01
Normal-vs-NonDiabetic
8.174000E-01
Diabetic-vs-NonDiabetic
4.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.783800E-01
Normal-vs-NoPancreatitis
7.822400E-01
Pancreatitis-vs-NoPancreatitis
8.444300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.443000E-01
Normal-vs-N1
8.481000E-01
N0-vs-N1
2.429200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.356400E-01
Normal-vs-TP53-NonMutant
5.412000E-01
TP53-Mutant-vs-TP53-NonMutant
7.246300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
